Страна: Великобритания
Язык: английский
Источник: VMD (Veterinary Medicines Directorate)
Canine parainfluenza virus, Feline coronavirus, Leptospira canicola, Leptospira icterohaemorrhagiae
Intervet UK Ltd
QI07AJ12
Canine parainfluenza virus, Feline coronavirus, Leptospira canicola, Leptospira icterohaemorrhagiae
Expired
Revised: February 2011 AN: 01799/2009 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quantum Dog Pi/CvL CMS except: Procyon Dog Pi/CvL Ireland; UK Procyon Pi/CvL vet Norway Quantum Perro Pi/CvL Spain Quantum Cão Pi/CvL Portugal Quantum Pi/CvL für Hunde Austria; Germany Lyophilisate and solvent for suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION i. Pi – freeze dried fraction ACTIVE SUBSTANCE (LIVE ATTENUATED) Quantity per dose (log 10 TCID 50 1 ) Canine parainfluenza virus (Philips Roxane strain) 4.8 – 6.1 ii. CvL – liquid diluent fraction ACTIVE SUBSTANCES (INACTIVATED) Quantity per 1 ml dose Feline coronavirus (strain FEC-SAH) > 6.3 log 2 SN units 2 _Leptospira_ _ _ _interrogans_ serovar _icterohaemorrhagiae _(strain 115) > 40 Hamster PD 80 3 _Leptospira interrogans _serovar _canicola_ (strain 117) > 40 Hamster PD 80 3 ADJUVANT Aluminium Hydroxide 1.63 -2.21 mg 1 Tissue culture infective dose 50% 2 Serum Neutralisation value in guinea pig potency test 3 Hamster protective dose 80% (Ph.Eur. monograph) EXCIPIENTS For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs Page 1 of 5 Revised: February 2011 AN: 01799/2009 4.2INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of dogs from 6 weeks of age: to prevent mortality and reduce clinical signs of disease caused by _Leptospira_ _interrogans_ serovars _canicola _and _icterohaemorrhagiae_; to reduce viral shedding of canine parainfluenza virus to reduce intestinal infection caused by canine coronavirus Immunity has been demonstrated from: 3 weeks after the primary vaccination course for parainfluenza (serological response on Прочитать полный документ